| First Author | Ostapchenko VG | Year | 2013 |
| Journal | J Neurochem | Volume | 127 |
| Issue | 3 | Pages | 415-25 |
| PubMed ID | 23651058 | Mgi Jnum | J:202644 |
| Mgi Id | MGI:5520148 | Doi | 10.1111/jnc.12296 |
| Citation | Ostapchenko VG, et al. (2013) Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease. J Neurochem 127(3):415-25 |
| abstractText | Prion protein (PrP(C) ), a glycosylphosphatidylinositol-anchored protein corrupted in prion diseases, has been shown recently to interact with group I metabotropic glutamate receptors (mGluRs). Moreover, both PrP(C) and mGluRs were proposed to function as putative receptors for beta-amyloid in Alzheimer's disease. PrP(C) can be processed in neurons via alpha or beta-cleavage to produce PrP(C) fragments that are neuroprotective or toxic, respectively. We found PrP(C) alpha-cleavage to be 2-3 times higher in the cortex of APPswe/PS1dE9 mice, a mouse model of Alzheimer's disease. A similar age-dependent increase was observed for PrP(C) beta-cleavage. Moreover, we observed considerable age-dependent increase in cortical expression of mGluR1, but not mGluR5. Exposure of cortical neuronal cultures to beta-amyloid oligomers upregulated mGluR1 and PrP(C) alpha-cleavage, while activation of group I mGluRs increased PrP(C) shedding from the membrane, likely due to increased levels of a disintegrin and metalloprotease10, a key disintegrin for PrP(C) shedding. Interestingly, a similar increase in a disintegrin and metalloprotease10 was detected in the cortex of 9-month-old APPswe/PS1dE9 animals. Our experiments reveal novel and complex processing of PrP(C) in connection with mGluR overexpression that seems to be triggered by beta-amyloid peptides. Prion protein (PrP(C) ) and metabotropic glutamate receptors (mGluR) are implicated in Alzheimer's disease (AD). We found age-dependent increase in PrP(C) processing, ADAM10 and mGluR1 levels in AD mouse model. These changes could be reproduced in cultured cortical neurons treated with Abeta peptide. Our findings suggest that increased levels of Abeta can trigger compensatory responses that may affect neuronal toxicity. |
